Superworth

Nautilus Biotechnology market cap NAUT

Share price times shares outstanding: what the whole company sells for, since 2020.

Today, Nov 2, 2026
$297.4M
Highest close in our data
$992.8M
Aug 2021

Nautilus Biotechnology is worth $297.4M at the close on Nov 2, 2026, at $2.34 a share.

That is up 56% over the last year and down 57% over five years.

Its highest close in our data was $992.8M in Aug 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$297.4M$112.7M$440.4M+19%
2025$250.1M$83.5M$284.2M+17%
2024$213.5M$213.5M$388.6M−43%
2023$373.6M$222M$497M+66%
2022$224.5M$193.3M$587.3M−65%
2021$643.2M$143.5M$992.8M+209%
2020$208.2M$195.7M$208.7Mn/a

Against its peers

Companies in Healthcare nearest Nautilus Biotechnology's size, closest first, today.

CompanyMarket cap
NAUTNautilus Biotechnology$297.4M
CYHCommunity Health Systems$296.2M
INFUInfuSystem$275.7M
EMBCEmbecta$350.7M
VMDViemed Healthcare$359.6M
UTMDUtah Medical Products$224.6M
ELMDElectromed$223.9M
NATRNatures Sunshine Products$211.5M
CRMDCorMedix$420.1M
PLXProtalix BioTherapeutics$206.3M
PDEXPro DEX$184.5M
Peer median$250.1M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Nautilus Biotechnology

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.